Dental Practitioners’ Formulary
The following list has been approved by the appropriate
Secretaries of State, and the preparations therein may be
prescribed by dental practitioners on form FP10D (GP14 in
Licensed sugar-free versions, where available, are preferred.
Licensed alcohol-free mouthwashes, where available, are
Aciclovir Oral Suspension, BP, 200 mg/5 mL
Amoxicillin Oral Suspension, BP
Artificial Saliva Oral Spray, DPF
Artificial Saliva Pastilles, DPF
Artificial Saliva Protective Spray, DPF
Artificial Saliva Substitutes as listed below (to be prescribed
only for indications approved by ACBS (patients suffering
from dry mouth as a result of having or, having undergone,
radiotherapy or sicca syndrome):
Artificial Saliva Substitute Spray, DPF
Aspirin Tablets, Dispersible, BP
Azithromycin Capsules, 250 mg, DPF
Azithromycin Oral Suspension, 200 mg/5 mL, DPF
Azithromycin Tablets, 250 mg, DPF
Azithromycin Tablets, 500 mg, DPF
Beclometasone Pressurised Inhalation, BP,
50 micrograms/metered inhalation, CFC-free, as:
Benzydamine Mouthwash, BP 0.15%
Benzydamine Oromucosal Spray, BP 0.15%
Betamethasone Soluble Tablets, 500 micrograms, DPF
Cetirizine Oral Solution, BP, 5 mg/5 mL
Chlorhexidine Gluconate Gel, BP
Chlorphenamine Oral Solution, BP
Choline Salicylate Dental Gel, BP
Clarithromycin Oral Suspension, 125 mg/5 mL, DPF
Clarithromycin Oral Suspension, 250 mg/5 mL, DPF
Co-amoxiclav Tablets, BP, 250/125 (amoxicillin 250 mg as
trihydrate, clavulanic acid 125 mg as potassium salt)
Co-amoxiclav Oral Suspension, BP, 125/31 (amoxicillin
125 mg as trihydrate, clavulanic acid 31.25 mg as
Co-amoxiclav Oral Suspension, BP, 250/62 (amoxicillin
250 mg as trihydrate, clavulanic acid 62.5 mg as potassium
Diazepam Oral Solution, BP, 2 mg/5 mL
Diclofenac Sodium Tablets, Gastro-resistant, BP
Dihydrocodeine Tablets, BP, 30 mg
Doxycycline Tablets, Dispersible, BP
Doxycycline Capsules, BP, 100 mg
Doxycycline Tablets, 20 mg, DPF
Erythromycin Ethyl Succinate Oral Suspension, BP
Erythromycin Ethyl Succinate Tablets, BP
Erythromycin Stearate Tablets, BP
Erythromycin Tablets, Gastro-resistant, BP
Fluconazole Capsules, 50 mg, DPF
Fluconazole Oral Suspension, 50 mg/5 mL, DPF
Hydrocortisone Oromucosal Tablets, BP
Hydrogen Peroxide Mouthwash, BP, 6%
Ibuprofen Oral Suspension, BP, sugar-free
Lansoprazole Capsules, Gastro-resistant, BP
Loratadine Syrup, 5 mg/5 mL, DPF
Menthol and Eucalyptus Inhalation, BP 1980
Metronidazole Oral Suspension, BP
Miconazole and Hydrocortisone Cream, BP
Miconazole and Hydrocortisone Ointment, BP
Omeprazole Capsules, Gastro-resistant, BP
Paracetamol Oral Suspension, BP
Paracetamol Tablets, Soluble, BP
Phenoxymethylpenicillin Oral Solution, BP
Phenoxymethylpenicillin Tablets, BP
Promethazine Hydrochloride Tablets, BP
Promethazine Oral Solution, BP
Saliva Stimulating Tablets, DPF
Sodium Chloride Mouthwash, Compound, BP
Sodium Fluoride Oral Drops, BP
Sodium Fluoride Toothpaste 0.619%, DPF
Sodium Fluoride Toothpaste 1.1%, DPF
Preparations in this list which are not included in the BP or
BPC are described under Details of DPF preparations.
For details of preparations that can be prescribed, see
individual entries under the relevant drug monographs
throughout the BNF publications.
Preparations on the List of Dental Preparations which are
specified as DPF are described as follows in the DPF.
Although brand names have sometimes been included for
identification purposes preparations on the list should be
prescribed by non-proprietary name.
amoxicillin (as trihydrate) 3 g sachet
BNF 78 Dental Practitioners’ Formulary 1615
Dental Practitioners’ Formulary
(proprietary product: Biotene Oralbalance), lactoperoxidase,
lactoferrin, lysozyme, glucose oxidase, xylitol in a gel basis
(proprietary product: Xerotin) consists of water, sorbitol,
carmellose (carboxymethylcellulose), potassium chloride,
sodium chloride, potassium phosphate, magnesium chloride,
calcium chloride and other ingredients, pH neutral
(proprietary product: Salivix), consists of acacia, malic acid,
Artificial Saliva Protective Spray
(proprietary product: Aquoral) consists of oxidised glycerol
triesters, silicon dioxide, flavouring agents, aspartame
Artificial Saliva Substitute Spray
(proprietary product: AS Saliva Orthana Spray) consists of
mucin, methylparaben, benzalkonium chloride, EDTA,
xylitol, peppermint oil, spearmint oil, mineral salts
Azithromycin Oral Suspension 200 mg/5 mL
azithromycin 200 mg/5 mL when reconstituted with water
azithromycin 250 mg and 500 mg
Betamethasone Soluble Tablets 500 micrograms
betamethasone (as sodium phosphate) 500 micrograms
(proprietary product: Corsodyl Oral Spray), chlorhexidine
Clarithromycin Oral Suspension 125 mg/5 mL
clarithromycin 125 mg/5 mL when reconstituted with water
Clarithromycin Oral Suspension 250 mg/5 mL
clarithromycin 250 mg/5 mL when reconstituted with water
(proprietary product: Periostat), doxycycline (as hyclate)
Fluconazole Oral Suspension 50 mg/5 mL
(proprietary product: Diflucan), fluconazole 50 mg/5 mL
(proprietary product: Xylocaine Spray), lidocaine 10%
supplying 10 mg lidocaine/spray
(proprietary product: SST), citric acid, malic acid and other
ingredients in a sorbitol base
Sodium Fluoride Toothpaste 0.619%
(proprietary product: Duraphat ‘2800 ppm’ Toothpaste),
Sodium Fluoride Toothpaste 1.1%
(proprietary product: Duraphat ‘5000 ppm’ Toothpaste),
1616 Dental Practitioners’ Formulary BNF 78
Dental Practitioners’ Formulary
Nurse Prescribers’ Formulary (NPF)
Nurse Prescribers’ Formulary for Community
List of preparations approved by the Secretary of State which
may be prescribed on form FP10P (form HS21(N) in Northern
Ireland, form GP10(N) in Scotland, forms WP10CN and
WP10PN in Wales) by Nurses for National Health Service
Community practitioners who have completed the
necessary training may only prescribe items appearing in the
nurse prescribers’ list set out below. Community Practitioner
Nurse Prescribers are recommended to prescribe generically,
except where this would not be clinically appropriate or
where there is no approved generic name.
Preparations on this list which are not included in the BP or
BPC are described under Details of NPF preparations.
Aspirin Tablets, Dispersible, 300 mg, BP (max. 96 tablets;
Bisacodyl Suppositories, BP (includes 5-mg and 10-mg
Catheter Maintenance Solution, Sodium Chloride, NPF
Catheter Maintenance Solution, ‘Solution G’, NPF
Catheter Maintenance Solution, ‘Solution R’, NPF
Chlorhexidine Gluconate Alcoholic Solutions containing at
Chlorhexidine Gluconate Aqueous Solutions containing at
Choline Salicylate Dental Gel, BP
Co-danthramer Capsules, Strong, NPF
Co-danthramer Oral Suspension, NPF
Co-danthramer Oral Suspension, Strong, NPF
Co-danthrusate Oral Suspension, NPF
Dimeticone barrier creams containing at least 10%
Docusate Oral Solution, Paediatric, BP
Eucerin ® Intensive 10% w/w Urea Treatment Cream
Eucerin ® Intensive 10% w/w Urea Treatment Lotion
Liquid and White Soft Paraffin Ointment, NPF
Neutrogena ® Norwegian Formula Dermatological Cream
Emollient Bath and Shower Preparations as listed below:
Balneum ® (except pack sizes that are not to be prescribed
under the NHS (see Part XVIIIA of the Drug Tariff, Part
XI of the Northern Ireland Drug Tariff))
Balneum Plus ® Bath Oil (except pack sizes that are not to
be prescribed under the NHS (see Part XVIIIA of the
Drug Tariff, Part XI of the Northern Ireland Drug Tariff))
Cetraben ® Emollient Bath Additive
Doublebase ® Emollient Bath Additive
Doublebase ® Emollient Shower Gel
Doublebase ® Emollient Wash Gel
Hydromol ® Bath and Shower Emollient
Oilatum ® Junior Bath Additive
Zerolatum ® Emollient Medicinal Bath Oil
Folic Acid Tablets 400 micrograms, BP
Ibuprofen Oral Suspension, BP (except for indications and
doses that are prescription-only)
Ibuprofen Tablets, BP (except for indications and doses that
Ispaghula Husk Granules, Effervescent, BP
Ispaghula Husk Oral Powder, BP
Lidocaine and Chlorhexidine Gel, BP
Macrogol Oral Liquid, Compound, NPF
Macrogol Oral Powder, Compound, NPF
Macrogol Oral Powder, Compound, Half-strength, NPF
Magnesium Hydroxide Mixture, BP
Malathion aqueous lotions containing at least 0.5%
Mebendazole Oral Suspension, NPF
Mouthwash Solution-tablets, NPF
Nicotine Inhalation Cartridge for Oromucosal Use, NPF
Nicotine Medicated Chewing Gum, NPF
Nicotine Sublingual Tablets, NPF
Nicotine Transdermal Patches, NPF
Paracetamol Oral Suspension, BP (includes 120 mg/5 mL and
250 mg/5 mL strengths—both of which are available as
BNF 78 Nurse Prescribers’ Formulary (NPF) 1617
Paracetamol Tablets, BP (max. 96 tablets; max. pack size
Paracetamol Tablets, Soluble, BP (includes 120-mg and
500-mg tablets; max. 96 tablets; max. pack size 32 tablets)
Senna and Ispaghula Granules, NPF
Sodium Chloride Solution, Sterile, BP
Sodium Citrate Compound Enema, NPF
Sodium Picosulfate Capsules, NPF
Sodium Picosulfate Elixir, NPF
Spermicidal contraceptives as listed below:
Sterculia and Frangula Granules, NPF
Zinc and Castor Oil Ointment, BP
Zinc Oxide and Dimeticone Spray, NPF
Zinc Oxide Impregnated Medicated Bandage, NPF
Zinc Oxide Impregnated Medicated Stocking, NPF
Zinc Paste and Ichthammol Bandage, BP 1993
Appliances and Reagents (including Wound
Community Practitioner Nurse Prescribers in England, Wales
and Northern Ireland can prescribe any appliance or reagent
in the relevant Drug Tariff. In the Scottish Drug Tariff,
Appliances and Reagents which may not be prescribed by
Appliances (including Contraceptive Devices) as listed in
Part IXA of the Drug Tariff (Part III of the Northern Ireland
Drug Tariff, Part 3 (Appliances) and Part 2 (Dressings) of the
Scottish Drug Tariff). (Where it is not appropriate for nurse
prescribers in family planning clinics to prescribe
contraceptive devices using form FP10(P) (forms WP10CN
and WP10PN in Wales), they may prescribe using the same
system as doctors in the clinic.)
Incontinence Appliances as listed in Part IXB of the Drug
Tariff (Part III of the Northern Ireland Drug Tariff, Part 5 of
Stoma Appliances and Associated Products as listed in
Part IXC of the Drug Tariff (Part III of the Northern Ireland
Drug Tariff, Part 6 of the Scottish Drug Tariff).
Chemical Reagents as listed in Part IXR of the Drug Tariff
(Part II of the Northern Ireland Drug Tariff, Part 9 of the
The Drug Tariffs can be accessed online at:
National Health Service Drug Tariff for England and Wales:
www.ppa.org.uk/ppa/edt_intro.htm
Health and Personal Social Services for Northern Ireland
Drug Tariff: www.hscbusiness.hscni.net/services/2034.htm
Scottish Drug Tariff: www.isdscotland.org/Health-topics/
Prescribing-and-Medicines/Scottish-Drug-Tariff/
Preparations on the Nurse Prescribers’ Formulary which are
not included in the BP or BPC are described as follows in the
Nurse Prescribers’ Formulary. Although brand names have
sometimes been included for identification purposes, it is
recommended that non-proprietary names should be used
for prescribing medicinal preparations in the NPF except
where a non-proprietary name is not available.
Catheter Maintenance Solution, Sodium Chloride
(proprietary products: OptiFlo S; Uro-Tainer Sodium Chloride;
Uriflex-S), sodium chloride 0.9%
Catheter Maintenance Solution, ‘Solution G’
(proprietary products: OptiFlo G; Uro-Tainer Suby G; Uriflex
G), citric acid 3.23%, magnesium oxide 0.38%, sodium
bicarbonate 0.7%, disodium edetate 0.01%
Catheter Maintenance Solution, ‘Solution R’
(proprietary products: OptiFlo R; Uro-Tainer Solution R;
Uriflex R), citric acid 6%, gluconolactone 0.6%, magnesium
carbonate 2.8%, disodium edetate 0.01%
Chlorhexidine gluconate alcoholic solutions
(proprietary products: ChloraPrep; Hydrex Solution; Hydrex
spray), chlorhexidine gluconate in alcoholic solution
Chlorhexidine gluconate aqueous solutions
(proprietary product: Unisept), chlorhexidine gluconate in
co-danthramer 25/200 (dantron 25 mg, poloxamer ‘188’
Co-danthramer Capsules, Strong P
co-danthramer 37.5/500 (dantron 37.5 mg, poloxamer ‘188’
Co-danthramer Oral Suspension P
(proprietary product: Codalax), co-danthramer 25/200 in
5 mL (dantron 25 mg, poloxamer ‘188’ 200 mg/5 mL)
Co-danthramer Oral Suspension, Strong P
(proprietary product: Codalax Forte), co-danthramer 75/1000
in 5 mL (dantron 75 mg, poloxamer ‘188’ 1 g/5 mL)
Co-danthrusate Oral Suspension P
(proprietary product: Normax), co-danthrusate 50/60
(dantron 50 mg, docusate sodium 60 mg/5 mL)
(proprietary products Conotrane Cream, dimeticone ‘350’
22%; Siopel Barrier Cream, dimeticone ‘1000’ 10%),
(proprietary product: Hedrin), dimeticone 4%
(proprietary product: Norgalax Micro-enema), docusate
Liquid and White Soft Paraffin Ointment
liquid paraffin 50%, white soft paraffin 50%
Macrogol Oral Liquid, Compound
(proprietary product: Movicol Liquid), macrogol ‘3350’
(polyethylene glycol ‘3350’) 13.125 g, sodium bicarbonate
178.5 mg, sodium chloride 350.7 mg, potassium chloride
Macrogol Oral Powder, Compound
(proprietary products: Laxido Orange, Molaxole, Movicol),
macrogol ‘3350’ (polyethylene glycol ‘3350’) 13.125 g,
sodium bicarbonate 178.5 mg, sodium chloride 350.7 mg,
potassium chloride 46.6 mg/sachet; (amount of potassium
chloride varies according to flavour of Movicol ® as follows:
plain-flavour (sugar-free) = 50.2 mg/sachet; lime and lemon
flavour = 46.6 mg/sachet; chocolate flavour = 31.7 mg/sachet.
1 sachet when reconstituted with 125 mL water provides K+
Macrogol Oral Powder, Compound, Half-strength
(proprietary product: Movicol-Half), macrogol ‘3350’
(polyethylene glycol ‘3350’) 6.563 g, sodium bicarbonate
89.3 g, sodium chloride 175.4 mg, potassium chloride
1618 Nurse Prescribers’ Formulary (NPF) BNF 78
(proprietary products: Derbac-M Liquid), malathion 0.5% in
(proprietary product: Vermox), mebendazole 100 mg/5 mL
(proprietary products: Ovex, Vermox), mebendazole 100 mg
(can be supplied for oral use in the treatment of enterobiasis
in adults and children over 2 years provided its container or
package is labelled to show a max. single dose of 100 mg and
it is supplied in a container or package containing not more
consist of tablets which may contain antimicrobial,
colouring and flavouring agents in a suitable soluble
effervescent basis to make a mouthwash
Nicotine Inhalation Cartridge for Oromucosal Use
(proprietary products: NicAssist Inhalator, Nicorette
Inhalator), nicotine 15 mg (for use with inhalation
mouthpiece; to be prescribed as either a starter pack
(6 cartridges with inhalator device and holder) or refill pack
(42 cartridges with inhalator device)
nicotine (as bitartrate) 1 mg or 2 mg (proprietary product:
Nicorette Mint Lozenge, Nicotinell Mint Lozenge), or nicotine
(as resinate) 1.5 mg, 2 mg, or 4 mg (proprietary product:
NiQuitin Lozenges, NiQuitin Minis, NiQuitin Pre-quit)
Nicotine Medicated Chewing Gum
(proprietary products: NicAssist Gum, Nicorette Gum,
Nicotinell Gum, NiQuitin Gum), nicotine 2 mg or 4 mg
(proprietary product: NicAssist Nasal Spray, Nicorette Nasal
Spray), nicotine 500 micrograms/metered spray
(proprietary product: Nicorette Quickmist), nicotine
(proprietary product: NicAssist Microtab, Nicorette Microtab),
nicotine (as a cyclodextrin complex) 2 mg (to be prescribed
as either a starter pack (2 6 15-tablet discs with dispenser)
or refill pack (7 6 15-tablet discs))
releasing in each 16 hours, nicotine approx. 5 mg, 10 mg, or
15 mg (proprietary products: Boots NicAssist Patch, Nicorette
Patch), or releasing in each 16 hours approx. 10 mg, 15 mg, or
25 mg (proprietary products: NicAssist Translucent Patch,
Nicorette Invisi Patch), or releasing in each 24 hours nicotine
approx. 7 mg, 14 mg, or 21 mg (proprietary products:
Nicopatch, Nicotinell TTS, NiQuitin, NiQuitin Clear)
(prescriber should specify the brand to be dispensed)
(proprietary product: Lyclear Dermal Cream), permethrin 5%
(proprietary product: Senokot Syrup), sennosides 7.5 mg/5 mL
No comments:
Post a Comment
اكتب تعليق حول الموضوع